Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A severely cholestatic liver graft can be successfully used in deceased donor liver transplantation.1 passage
• A successful case of deceased donor liver transplantation for a patient with intrahepatic arterioportal fistula.1 passage
• Acute exacerbation of hepatitis B with hepatic failure during the first trimester of pregnancy: Delivery of a healthy term baby after liver transplantation.1 passage
• Acute liver failure due to severe Herpes simplex viral hepatitis in an elderly woman: A case of initial infection.1 passage
• Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course.1 passage
• Case report of diet-related improvements of non-alcoholic steatohepatitis evaluated by four consecutive liver biopsies.1 passage
• Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.1 passage
• Chronic hepatitis without hepatic steatosis caused by citrin deficiency in a child.1 passage
• Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report.1 passage
• Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases.1 passage
• Daclatasvir and asunaprevir for recurrent hepatitis C following living donor liver transplantation with HIV co-infection.1 passage
• Discrepant diagnostic results using two genotyping methods in a chronic hepatitis C patient in serogroup 1.1 passage
• Favorable response to immunosuppressive combination therapy with mizoribine and azathioprine in children with primary sclerosing cholangitis.1 passage
• Follicular cholangitis mimicking cholangiocarcinoma treated with right hepatectomy: A case report and review of published works.1 passage
• Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.1 passage
• Hepatocellular carcinoma developed in a living donor after left lobe donation: a case for caution.1 passage
• Immunoglobulin G4-associated autoimmune hepatitis later complicated by autoimmune pancreatitis: A case report.1 passage
• Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.1 passage
• Intraductal tubulopapillary neoplasm of the bile duct: A case report and review of the published work.1 passage
• Long-term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion.1 passage
• Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis.1 passage
• Morbidly obese patient with non-alcoholic steatohepatitis-related cirrhosis who died from sepsis caused by dental infection of Porphyromonas gingivalis: A case report.1 passage
• Non-response to daclatasvir and asunaprevir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2.1 passage
• Primary liver carcinoma with sarcomatous changes: Analysis of 10 cases.1 passage
• Response to crizotinib in a patient with MET-amplified hepatocellular carcinoma.1 passage
• Secondary sclerosing cholangitis with hemobilia induced by pembrolizumab: Case report and review of published work.1 passage
• Significant improvement in portal-systemic liver failure symptoms and successful management of portal-splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy.1 passage
• Spontaneous regression of hepatocellular carcinoma with reduction in angiogenesis-related cytokines after treatment with sodium-glucose cotransporter 2 inhibitor in a cirrhotic patient with diabetes mellitus.1 passage
• Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C.1 passage
• Successful achievement of sustained virological response to triple combination therapy containing simeprevir in two patients with chronic hepatitis C who had failed asunaprevir:Daclatasvir combination therapy.1 passage
• Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases.1 passage
• Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b.1 passage
• Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report.1 passage
• Time-resolved 3D cine phase-contrast magnetic resonance imaging (4D-flow MRI) can quantitatively assess portosystemic shunt severity and confirm normalization of portal flow after embolization of large portosystemic shunts.1 passage
• Two hepatectomy cases for initially unresectable hepatocellular carcinoma after achieving a radiological complete response to sequential therapy with lenvatinib and transcatheter arterial chemoembolization.1 passage
• Unexpected hepatitis B virus transmission after liver transplant from nucleic acid testing- and serology-negative liver donors who are hepatitis C viremic.1 passage
• Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir.1 passage